ArticleFrontiers in oncology2024

Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility study.

Renxian Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.